Sample Tracking Using Unique Sequence Controls.


Journal

The Journal of molecular diagnostics : JMD
ISSN: 1943-7811
Titre abrégé: J Mol Diagn
Pays: United States
ID NLM: 100893612

Informations de publication

Date de publication:
02 2020
Historique:
received: 19 07 2019
revised: 27 09 2019
accepted: 24 10 2019
pubmed: 15 12 2019
medline: 13 5 2021
entrez: 15 12 2019
Statut: ppublish

Résumé

Sample tracking and identity are essential when processing multiple samples in parallel. Sequencing applications often involve high sample numbers, and the data are frequently used in a clinical setting. As such, a simple and accurate intrinsic sample tracking process through a sequencing pipeline is essential. Various solutions have been implemented to verify sample identity, including variant detection at the start and end of the pipeline using arrays or genotyping, bioinformatic comparisons, and optical barcoding of samples. None of these approaches are optimal. To establish a more effective approach using genetic barcoding, we developed a panel of unique DNA sequences cloned into a common vector. A unique DNA sequence is added to the sample when it is first received and can be detected by PCR and/or sequencing at any stage of the process. The control sequences are approximately 200 bases long with low identity to any sequence in the National Center for Biotechnology Information nonredundant database (<30 bases) and contain no long homopolymer (>7) stretches. When a spiked next-generation sequencing library is sequenced, sequence reads derived from this control sequence are generated along with the standard sequencing run and are used to confirm sample identity and determine cross-contamination levels. This approach is used in our targeted clinical diagnostic whole-genome and RNA-sequencing pipelines and is an inexpensive, flexible, and platform-agnostic solution.

Identifiants

pubmed: 31837431
pii: S1525-1578(19)30436-2
doi: 10.1016/j.jmoldx.2019.10.011
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-146

Informations de copyright

Copyright © 2020 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Auteurs

Richard A Moore (RA)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia; Faculty of Health Science, Simon Fraser University, Burnaby, British Columbia. Electronic address: rmoore@bcgsc.ca.

Thomas Zeng (T)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia.

T Roderick Docking (TR)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia.

Ian Bosdet (I)

Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Yaron S Butterfield (YS)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia.

Sarah Munro (S)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia.

Irene Li (I)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia.

Lucas Swanson (L)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia.

Elizabeth R Starks (ER)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia.

Kane Tse (K)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia.

Andrew J Mungall (AJ)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia.

Robert A Holt (RA)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

Aly Karsan (A)

Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: akarsan@bcgsc.ca.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH